Yüklüyor......
Tumor Growth Dynamic Modeling in Oncology Drug Development and Regulatory Approval: Past, Present, and Future Opportunities
Model‐informed drug development (MIDD) approaches have rapidly advanced in drug development in recent years. Additionally, the Prescription Drug User Fee Act (PDUFA) VI has specific commitments to further enhance MIDD. Tumor growth dynamic (TGD) modeling, as one of the commonly utilized MIDD approac...
Kaydedildi:
| Yayımlandı: | CPT Pharmacometrics Syst Pharmacol |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7438808/ https://ncbi.nlm.nih.gov/pubmed/32589767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/psp4.12542 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|